FeesSafety
Pluang+

BellRing shares jump 24% on strong sales and upbeat earnings forecast

Company Fundamentals
19 Nov 2026, 08:52 WIB
Joe Tenebruso
View Source
Bullish
BellRing shares jump 24% on strong sales and upbeat earnings forecast

BellRing Brands saw a 24% surge in its stock price after reporting a 7% increase in net sales to $692 million for fiscal 2026 Q4, driven by strong demand for its high-protein Premier Protein shakes and new product launches like Sparkling Protein Soda. The company also secured a major distribution deal with 7-Eleven to expand its reach. Despite rising costs, BellRing's new CEO plans to save $100 million through supply chain optimizations, aiming to boost EBITDA to $310-$350 million in fiscal 2027, up from $289 million in 2026.

BellRing Brands saw a strong stock surge today. For readers following the Consumer Staples sector, here is Pluang's market snapshot as of Nov 19, 2026 09:11 WIB: Of 62 priced US stocks, 25 rose and 37 fell. Notable movers include Herbalife Nutrition Ltd (HLF) at USD 16.12 with a 3.53% increase and 100% sell order activity, Kroger Co (KR) at USD 68.69 down 3.09% with 98% sell orders, and Campbell Soup Co. (CPB) at USD 24.29 up 3.01% with 100% sell orders.

More News

Anthropic plans IPO to fund AI-driven bioscience, with potential future ties to Ginkgo Bioworks' lab automation.

Anthropic plans IPO to fund AI-driven bioscience, with potential future ties to Ginkgo Bioworks' lab automation.

Anthropic is set to go public on November 19, raising tens of billions to boost its AI capabilities in bioscience, focusing on lab automation and robotics. Ginkgo Bioworks, a leader in automated biotech labs, collaborates with OpenAI but has no curre...

Market News
Bullish
16 minutes ago
Analyst cuts Peabody Energy price target by nearly 30% but keeps buy rating.

Analyst cuts Peabody Energy price target by nearly 30% but keeps buy rating.

Freedom Broker analyst Vitaly Kononov lowered Peabody Energy's price target from $30 to $22 per share, citing reduced production outlooks at its key Centurion coal mine and vulnerability in coal prices. Despite the significant cut, he maintained a bu...

Analyst Insights
Bearish
1 hour ago
Micron's strong growth and rising stock price hint at a possible future stock split.

Micron's strong growth and rising stock price hint at a possible future stock split.

Micron Technology is showing strong financial growth, driven by its crucial role in AI infrastructure and multiyear deals with key tech companies. The company recently beat revenue expectations with a 379% year-over-year increase and projects even be...

Company Fundamentals
Bullish
1 hour ago
FDA approves Livsayis™, first siRNA therapy for generalized myasthenia gravis, offering new treatment option.

FDA approves Livsayis™, first siRNA therapy for generalized myasthenia gravis, offering new treatment option.

The FDA has approved Livsayis™ (cemdisiran), the first and only siRNA therapy for adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor antibody-positive. This subcutaneous treatment, administered four times a year, targ...

Market News
Bullish
1 hour ago
Elauwit reports 66% growth in monthly recurring revenue to $539K, cutting expenses and expanding managed Wi-Fi networks.

Elauwit reports 66% growth in monthly recurring revenue to $539K, cutting expenses and expanding managed Wi-Fi networks.

Elauwit announced a 66% year-over-year increase in monthly recurring revenue to $539,000 by the end of Q3 2026, driven by long-term contracts for managed Wi-Fi in apartment communities. The company also reduced operating expenses by 19% sequentially ...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App